Physician-supervised GLP-1 programs with compounded semaglutide and tirzepatide. Clinically proven results—not willpower, not guesswork.
Naya Wellness has been treating patients since 2007. Our medical weight loss program uses the latest GLP-1 and dual GLP-1/GIP receptor agonists to address the hormonal drivers of weight gain—with in-person care in Chatsworth and Santa Barbara, and telehealth available to patients anywhere in California.
In-person care in Chatsworth and Santa Barbara, or virtual consultations for patients anywhere in California. Select your preferred option below.
San Fernando Valley clinic serving Chatsworth, Woodland Hills, West Hills, Northridge, and surrounding areas. In-person visits with full clinical support.
Learn MoreCentral Coast clinic serving Santa Barbara, Montecito, Goleta, and Ventura County. In-person visits with complete medical weight loss programs.
Learn MoreAccess Naya's full GLP-1 weight loss program from anywhere in California. Virtual consultations, prescriptions, and ongoing monitoring — all online.
Learn MoreObesity isn't a willpower problem. It's a hormonal and metabolic condition—and it requires a medical solution.
When you cut calories, your body fights back. Ghrelin—the hunger hormone—rises sharply. Your metabolism slows. Cravings intensify. This is why 95% of traditional diets fail long-term: you're working against your own biology.
GLP-1 receptor agonists change this equation. They reduce appetite at the hormonal level, slow gastric emptying, improve insulin sensitivity, and help your body reach and maintain a lower weight set point—without the same hormonal backlash.
Both medications are highly effective. Your Naya provider will recommend the right choice based on your health history, goals, and how your body responds.
| Feature | Compounded Semaglutide | Compounded Tirzepatide |
|---|---|---|
| Mechanism | GLP-1 receptor agonist | Dual GLP-1 + GIP receptor agonist |
| Average weight loss | ~15–20% of body weight | ~20–22% of body weight |
| Dosing frequency | Once weekly injection | Once weekly injection |
| Good for | Most patients; first-line option | Patients wanting maximum efficacy or those who've plateaued on semaglutide |
| Common side effects | Nausea, reduced appetite (typically mild) | Similar to semaglutide; often better tolerated |
A structured, supported process from first visit to ongoing care.
Your provider reviews your health history, goals, and prior weight loss attempts.
Baseline labs to assess metabolic health, thyroid, and eligibility for GLP-1 therapy.
Prescription sent to a licensed compounding pharmacy. Low-dose start with gradual titration.
Regular check-ins to track progress, adjust dosing, and manage any side effects.
Nutritional guidance and lifestyle coaching alongside your medication program.
Weight Loss Optimization Membership provides continued access to medications and monitoring.
GLP-1 medications are among the most studied weight loss interventions available. Naya follows evidence-based protocols to maximize safety and efficacy.
GLP-1 medications are not appropriate for patients with a personal or family history of medullary thyroid carcinoma or MEN2. Your provider will screen for all contraindications before starting treatment.
Medical weight loss uses prescription medications—like GLP-1 receptor agonists—alongside clinical oversight to help patients achieve meaningful, sustained weight loss. Unlike diet programs or over-the-counter supplements, medical weight loss addresses the hormonal and metabolic drivers of obesity with proven, FDA-authorized compounds. At Naya, programs are supervised by experienced nurse practitioners who adjust your protocol based on your results and health status.
Naya uses compounded semaglutide (a GLP-1 receptor agonist) and compounded tirzepatide (a dual GLP-1/GIP receptor agonist). Both are prescribed based on your health history, goals, and tolerance. Average weight loss is 15–20% with semaglutide and 20–22% with tirzepatide. Your provider will recommend the right medication based on your individual profile.
Naya prescribes compounded semaglutide and tirzepatide prepared by licensed U.S. 503A compounding pharmacies. Compounded versions contain the same active ingredient as brand-name GLP-1 medications but are often more affordable and more accessible when brand-name supply is limited. Compounding pharmacies used by Naya are state-licensed and comply with USP standards.
Clinical data shows average weight loss of 15–20% of body weight with semaglutide over 68 weeks, and 20–22% with tirzepatide over 72 weeks. Individual results vary based on starting weight, adherence to the program, and lifestyle factors. Most patients notice meaningful appetite reduction within the first 2–4 weeks of treatment.
Both options are available. Naya has in-person clinics in Chatsworth and Santa Barbara. California patients who prefer virtual care can access the full program via telehealth—consultations, prescriptions, and follow-up appointments are all conducted online. After your consultation and prescription, medication is shipped directly to your home anywhere in California from the pharmacy, with shipping and handling included.
Where your medications come from
Naya prepares compounded treatments through LegitScript-certified compounding pharmacies and accredited diagnostic labs. See our pharmacy & lab partners →
Naya Wellness medical weight loss programs include physician evaluation, GLP-1 medication when appropriate, nutrition guidance, and ongoing progress monitoring.
Most patients notice reduced appetite in the first one to two weeks, with meaningful weight loss occurring over three to six months of consistent treatment.
GLP-1 medications have been studied for multi-year use and are FDA-cleared for chronic weight management in eligible patients.
A maintenance plan is developed with your Naya Wellness provider to sustain results through lifestyle support and, when indicated, continued medication.
Naya Wellness now offers Medical Weight Loss at our Santa Barbara clinic — serving Montecito, Goleta & the South Coast.
View Medical Weight Loss in Santa Barbara